Damien Gallagher1, Alex Kiss2, Krista Lanctot3, Nathan Herrmann4. 1. Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada. Electronic address: damien.gallagher@sunnybrook.ca. 2. Sunnybrook Research Institute and Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. 3. Sunnybrook Research Institute and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute and Department of Toxicology, University of Toronto, Toronto, Ontario, Canada. 4. Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: Older adults with depression are at increased risk of Alzheimer dementia, but predictors of increased risk remain incompletely understood. We aim to identify characteristics of older adults with depression most at risk of progressing to Alzheimer dementia. Identification of high-risk subgroups could facilitate future interventional strategies to reduce risk of Alzheimer dementia in older adults with depression. METHODS: Using data from the National Alzheimer's Coordinating Center, 1,965 participants with clinically defined depression and mild cognitive impairment at baseline were followed until development of Alzheimer dementia or loss to follow-up. RESULTS: Seven hundred and eighty (39.7%) developed Alzheimer dementia over a median follow-up duration of 27 months. In survival analyses, age (hazard ratio [HR] 1.04, 95% 1.03-1.05), baseline Mini-Mental State Exam (HR 0.85, 95% confidence interval 0.83-0.87), amnestic subtype of mild cognitive impairment (HR 1.66, 95% 1.30-2.12), presence of APOE4 allele (HR 1.99, 1.69-2.36), and presence of active depression within the last two years (HR 1.44, 95% confidence interval 1.16-1.79) were all independently associated with increased risk of Alzheimer dementia. Six hundred and fifty-six (41.7%) participants with mild cognitive impairment and active depression within the last two years developed Alzheimer dementia compared to 120 (31.6%) of those with a more remote history of depression. CONCLUSION: Older adults with depression and mild cognitive impairment demonstrated a high rate of progression to Alzheimer dementia over a relatively short duration of follow-up. Individuals with a combination of mild cognitive impairment and recently active depression are a particularly high-risk subgroup.
OBJECTIVE: Older adults with depression are at increased risk of Alzheimer dementia, but predictors of increased risk remain incompletely understood. We aim to identify characteristics of older adults with depression most at risk of progressing to Alzheimer dementia. Identification of high-risk subgroups could facilitate future interventional strategies to reduce risk of Alzheimer dementia in older adults with depression. METHODS: Using data from the National Alzheimer's Coordinating Center, 1,965 participants with clinically defined depression and mild cognitive impairment at baseline were followed until development of Alzheimer dementia or loss to follow-up. RESULTS: Seven hundred and eighty (39.7%) developed Alzheimer dementia over a median follow-up duration of 27 months. In survival analyses, age (hazard ratio [HR] 1.04, 95% 1.03-1.05), baseline Mini-Mental State Exam (HR 0.85, 95% confidence interval 0.83-0.87), amnestic subtype of mild cognitive impairment (HR 1.66, 95% 1.30-2.12), presence of APOE4 allele (HR 1.99, 1.69-2.36), and presence of active depression within the last two years (HR 1.44, 95% confidence interval 1.16-1.79) were all independently associated with increased risk of Alzheimer dementia. Six hundred and fifty-six (41.7%) participants with mild cognitive impairment and active depression within the last two years developed Alzheimer dementia compared to 120 (31.6%) of those with a more remote history of depression. CONCLUSION: Older adults with depression and mild cognitive impairment demonstrated a high rate of progression to Alzheimer dementia over a relatively short duration of follow-up. Individuals with a combination of mild cognitive impairment and recently active depression are a particularly high-risk subgroup.
Authors: Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-05-12 Impact factor: 5.067
Authors: Damien Gallagher; Aine Ni Mhaolain; Elaine Greene; Cathal Walsh; Aisling Denihan; Irene Bruce; Jeannette Golden; Ronan M Conroy; Michael Kirby; Brian A Lawlor Journal: Int J Geriatr Psychiatry Date: 2010-10 Impact factor: 3.485
Authors: John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: Benoit H Mulsant; Aristotle N Voineskos; Neda Rashidi-Ranjbar; Tarek K Rajji; Sanjeev Kumar; Nathan Herrmann; Linda Mah; Alastair J Flint; Corinne E Fischer; Meryl A Butters; Bruce G Pollock; Erin W Dickie; John A E Anderson Journal: Neuropsychopharmacology Date: 2020-05-18 Impact factor: 7.853
Authors: Ganesh M Babulal; Catherine M Roe; Sarah H Stout; Ganesh Rajasekar; Julie K Wisch; Tammie L S Benzinger; John C Morris; Beau M Ances Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Doyoung Kim; RuoDing Wang; Alex Kiss; Susan E Bronskill; Krista L Lanctot; Nathan Herrmann; Damien Gallagher Journal: Am J Geriatr Psychiatry Date: 2021-01-06 Impact factor: 7.996
Authors: Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson Journal: Curr Psychiatry Rep Date: 2021-07-13 Impact factor: 8.081
Authors: Katharine K Brewster; Mei-Chen Hu; Sigal Zilcha-Mano; Alexandra Stein; Patrick J Brown; Melanie M Wall; Steven P Roose; Justin S Golub; Bret R Rutherford Journal: J Gerontol A Biol Sci Med Sci Date: 2021-04-30 Impact factor: 6.591